NR546 FINAL EXAM – ADVANCED PATHOPHYSIOLOGY AND
PHARMACOLOGY FOR NURSE PRACTITIONERS - (120
QUESTIONS) UP-TO-DATE ACTUAL EXAM QUESTIONS AND 100%
ACCURATE SOLUTIONS | VERIFIED ANSWERS - INSTANT PDF
DOWNLOAD
Candidate Name: _______________________________
Candidate ID: _________________________________
Date: ________________________________________
Examination Center: ____________________________
Time Allowed: 180 Minutes
Total Questions: 120
Candidate Instructions:
Read all questions carefully before selecting your answer. Each question has
only one correct answer. You are expected to apply advanced clinical
reasoning integrating pathophysiology and pharmacology principles. Manage
your time effectively to ensure completion of all 120 questions within the
allotted 180 minutes. Do not leave any question unanswered. Calculators are
not required. Clinical judgment and evidence-based reasoning are essential
for success.
Disclaimer:
This examination is an original simulation designed for educational purposes. It
reflects the structure and rigor of advanced nurse practitioner-level assessments
but does not replicate any official or proprietary examination.
Core Competency Areas:
• Advanced Cardiovascular Pathophysiology and Pharmacotherapy
• Endocrine and Metabolic Disorders
• Renal and Electrolyte Imbalances
• Pulmonary Disorders and Therapeutics
• Neurophysiology and Neuropharmacology
, • Infectious Diseases and Antimicrobial Stewardship
• Pharmacokinetics and Pharmacodynamics
• Clinical Decision-Making and Patient Safety
This assessment evaluates advanced clinical knowledge required for nurse
practitioners managing complex patient conditions. Candidates must
demonstrate the ability to integrate pathophysiologic mechanisms with
pharmacologic interventions, ensuring safe, effective, and individualized
patient care across diverse populations.
Q1.
A 62-year-old male with long-standing hypertension presents with left
ventricular hypertrophy. Which pathophysiologic mechanism primarily
contributes to this condition?
A. Increased preload due to volume overload
B. Chronic pressure overload leading to myocardial fiber thickening
C. Decreased afterload resulting in myocardial dilation
D. Impaired calcium influx causing myocardial atrophy
Correct Answer: B. Chronic pressure overload leading to myocardial
fiber thickening
Explanation: Chronic hypertension increases afterload, forcing the left
ventricle to generate higher pressure. This results in concentric hypertrophy
due to myocardial fiber thickening. A is incorrect as preload relates to volume,
not pressure. C is incorrect because decreased afterload reduces cardiac
workload. D is incorrect as calcium impairment leads to contractility issues, not
hypertrophy.
,Q2.
A patient with type 2 diabetes is started on metformin. What is its primary
mechanism of action?
A. Stimulates insulin secretion from beta cells
B. Increases peripheral insulin sensitivity and decreases hepatic glucose
production
C. Delays intestinal carbohydrate absorption exclusively
D. Blocks renal glucose reabsorption
Correct Answer: B. Increases peripheral insulin sensitivity and
decreases hepatic glucose production
Explanation: Metformin reduces hepatic gluconeogenesis and improves
insulin sensitivity. A describes sulfonylureas. C relates to alpha-glucosidase
inhibitors. D describes SGLT2 inhibitors.
Q3.
A patient develops hyperkalemia after starting an ACE inhibitor. What is the
underlying mechanism?
A. Increased aldosterone secretion
B. Reduced renal potassium excretion due to decreased aldosterone
C. Enhanced sodium reabsorption
D. Increased distal nephron potassium secretion
Correct Answer: B. Reduced renal potassium excretion due to
decreased aldosterone
Explanation: ACE inhibitors decrease aldosterone, reducing potassium
, excretion and causing hyperkalemia. A is opposite. C does not explain
potassium retention. D is incorrect as potassium secretion decreases.
Q4.
Which receptor is primarily responsible for bronchodilation when activated by
beta-agonists?
A. Alpha-1 receptor
B. Beta-1 receptor
C. Beta-2 receptor
D. Muscarinic receptor
Correct Answer: C. Beta-2 receptor
Explanation: Beta-2 receptor activation relaxes bronchial smooth muscle. A
causes vasoconstriction. B affects heart rate. D causes bronchoconstriction.
Q5.
A patient on warfarin therapy presents with elevated INR. Which factor is most
affected?
A. Factor VIII
B. Factor X
C. Factor XIII
D. Factor V
PHARMACOLOGY FOR NURSE PRACTITIONERS - (120
QUESTIONS) UP-TO-DATE ACTUAL EXAM QUESTIONS AND 100%
ACCURATE SOLUTIONS | VERIFIED ANSWERS - INSTANT PDF
DOWNLOAD
Candidate Name: _______________________________
Candidate ID: _________________________________
Date: ________________________________________
Examination Center: ____________________________
Time Allowed: 180 Minutes
Total Questions: 120
Candidate Instructions:
Read all questions carefully before selecting your answer. Each question has
only one correct answer. You are expected to apply advanced clinical
reasoning integrating pathophysiology and pharmacology principles. Manage
your time effectively to ensure completion of all 120 questions within the
allotted 180 minutes. Do not leave any question unanswered. Calculators are
not required. Clinical judgment and evidence-based reasoning are essential
for success.
Disclaimer:
This examination is an original simulation designed for educational purposes. It
reflects the structure and rigor of advanced nurse practitioner-level assessments
but does not replicate any official or proprietary examination.
Core Competency Areas:
• Advanced Cardiovascular Pathophysiology and Pharmacotherapy
• Endocrine and Metabolic Disorders
• Renal and Electrolyte Imbalances
• Pulmonary Disorders and Therapeutics
• Neurophysiology and Neuropharmacology
, • Infectious Diseases and Antimicrobial Stewardship
• Pharmacokinetics and Pharmacodynamics
• Clinical Decision-Making and Patient Safety
This assessment evaluates advanced clinical knowledge required for nurse
practitioners managing complex patient conditions. Candidates must
demonstrate the ability to integrate pathophysiologic mechanisms with
pharmacologic interventions, ensuring safe, effective, and individualized
patient care across diverse populations.
Q1.
A 62-year-old male with long-standing hypertension presents with left
ventricular hypertrophy. Which pathophysiologic mechanism primarily
contributes to this condition?
A. Increased preload due to volume overload
B. Chronic pressure overload leading to myocardial fiber thickening
C. Decreased afterload resulting in myocardial dilation
D. Impaired calcium influx causing myocardial atrophy
Correct Answer: B. Chronic pressure overload leading to myocardial
fiber thickening
Explanation: Chronic hypertension increases afterload, forcing the left
ventricle to generate higher pressure. This results in concentric hypertrophy
due to myocardial fiber thickening. A is incorrect as preload relates to volume,
not pressure. C is incorrect because decreased afterload reduces cardiac
workload. D is incorrect as calcium impairment leads to contractility issues, not
hypertrophy.
,Q2.
A patient with type 2 diabetes is started on metformin. What is its primary
mechanism of action?
A. Stimulates insulin secretion from beta cells
B. Increases peripheral insulin sensitivity and decreases hepatic glucose
production
C. Delays intestinal carbohydrate absorption exclusively
D. Blocks renal glucose reabsorption
Correct Answer: B. Increases peripheral insulin sensitivity and
decreases hepatic glucose production
Explanation: Metformin reduces hepatic gluconeogenesis and improves
insulin sensitivity. A describes sulfonylureas. C relates to alpha-glucosidase
inhibitors. D describes SGLT2 inhibitors.
Q3.
A patient develops hyperkalemia after starting an ACE inhibitor. What is the
underlying mechanism?
A. Increased aldosterone secretion
B. Reduced renal potassium excretion due to decreased aldosterone
C. Enhanced sodium reabsorption
D. Increased distal nephron potassium secretion
Correct Answer: B. Reduced renal potassium excretion due to
decreased aldosterone
Explanation: ACE inhibitors decrease aldosterone, reducing potassium
, excretion and causing hyperkalemia. A is opposite. C does not explain
potassium retention. D is incorrect as potassium secretion decreases.
Q4.
Which receptor is primarily responsible for bronchodilation when activated by
beta-agonists?
A. Alpha-1 receptor
B. Beta-1 receptor
C. Beta-2 receptor
D. Muscarinic receptor
Correct Answer: C. Beta-2 receptor
Explanation: Beta-2 receptor activation relaxes bronchial smooth muscle. A
causes vasoconstriction. B affects heart rate. D causes bronchoconstriction.
Q5.
A patient on warfarin therapy presents with elevated INR. Which factor is most
affected?
A. Factor VIII
B. Factor X
C. Factor XIII
D. Factor V
